[The effect of oral contraceptives on plasma renin activity and plasma renin substrate concentration (author's transl)].
D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D000804:Angiotensin II / Q000097:blood; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005246:Feedback; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008099:Liver / Q000378:metabolism; D008234:Lynestrenol / Q000494:pharmacology; D008535:Megestrol / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D009644:Norgestrel / Q000494:pharmacology; D011863:Radioimmunoassay; D012083:Renin / Q000097:blood*; D013268:Stimulation, Chemical; D013997:Time Factors
D003276:Contraceptives, Oral; D004338:Drug Combinations; D000804:Angiotensin II; D009644:Norgestrel; D004997:Ethinyl Estradiol; D000450:Aldosterone; D008535:Megestrol; D012083:Renin; D008234:Lynestrenol; D009640:Norethindrone
Beeinflussung der Reninaktivität und der Reninsubstratkonzentration im Plasma durch orale Contraceptiva